Press Releases

Dignitana AB Publishes Interim Report for Q2 2018

Solid progress and growth

Dignitana AB  today posted the company's Interim Report for the period ending 30 June 2018. Dignitana has shown a 51 percent increase in sales over the first quarter 2018. 

"The results we posted this quarter represent a very important milestone for Dignitana. Quarterly revenue for the company reached 9,022 TSEK. With the organizational restructuring we have implemented, the company is close to reaching a breakeven point in regard to our costs for continuing operations."  - William Cronin, CEO, Dignitana AB

To download the full report click here.

This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Market Act. The information was submitted for publication, by the above contact, for publication at 8:00 (CET), 21 August 2018. 

This press release has been prepared in both Swedish and English versions. In the event of discrepancies between the two versions, the English version shall govern.

William Cronin, CEO, Dignitana AB  bill.cronin@dignitana.com +1 469 917 5555
Mikael Wahlgren, Vice VD, Dignitana AB  mikael.wahlgren@dignitana.com   +46 709 33 72 20

About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser.  Learn more at www.dignitana.se and www.dignicap.com.

2018-07-20
Regulatory
1
2
...
10
>>

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90